Genitope Corporation · Fremont, CA United States (Pink Sheets: GTOP)
| 6900 Dumbarton Circle | Phone: 510-284-3000 |
| Fremont, CA | Fax: 512-284-3100 |
| 94555 | |
| United States | 
Map This Company |
Genitope Corporation Rankings
More Companies in These Related Industries: Biologics MfgCompany Description
Genitope is a drug development company in arrested development. It had hoped to find new ways to fight cancer with old weapons, but now it is just hoping to find a future. The company was researching immunotherapy treatments for cancer, using the body's own immune system to fight tumors. Genitope's leading drug candidate, MyVax, was a patient-specific immunotherapy that would specify the genetic makeup of the tumor, activate the patient's immune system to attack it, and cause no damage to cells other than the tumor. However, the drug did not do well in early clinical trials, and when the FDA requested additional trials for further review, Genitope chose to scrap the whole program.
Genitope Corporation Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - Pink Sheets: GTOP Single Location |
|---|---|
| Fiscal Year-End | December |
| 2007 Employees | 206 |
Executives
11 executives listed for Genitope Corporation's Fremont, CA location.
| Chairman, CEO, Interim CFO, and Principal Financial Officer | Dan Denney | |
|---|---|---|
| VP Information Technology | H. David Miller | |
| VP Medical Affairs and Chief Medical Officer | Mary Ellen Rybak |